Feb 14, 2023
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.11 to $0.00.
The split itself did not change the total investment value.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) trades on the NASDAQ in the Biotechnology industry.
Corbus Pharmaceuticals Holdings, Inc. company overviewThe latest split shown was on February 14, 2023. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records one reverse split, on February 14, 2023.